Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction ended on 26.02.26 with a price of €6.30. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.22%. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Biocryst Pharmaceuticals	-1.323%	-1.323%	3.335%
iShares Core DAX®	-6.016%	-4.595%	1.284%
iShares Nasdaq 100	0.511%	0.164%	14.401%
iShares Nikkei 225®	-7.156%	-2.215%	27.886%
iShares S&P 500	-0.257%	-0.841%	10.254%